Cord blood banking is defined as the collection and storage of stem cells present within the umbilical cord blood of a newborn for future medical use. Umbilical cord blood is rich in a type of stem cell known as a hematopoietic stem cell (HSC). A large market for the storage of these cells has come into existence over the past 30 years, with public and private cord blood banks now present in all major healthcare markets worldwide. [Read more…]
The Best Cord Blood Bank of 2023: Which One Should You Choose?
After choosing a name for your newborn, the next decision you’ll need to make is whether or not you want to save their cord blood. It’s a choice you will need to make swiftly, as the window to successfully store your child’s cord blood and cord tissue is a relatively small one.
While there is a lot of information available for expecting parents, sifting through all the options to find the best cord blood bank can be overwhelming, especially if you’re not exactly familiar with all the terms and technology. [Read more…]
Cord Blood in the Era of Regenerative Medicine
Cord blood is the blood present in the umbilical cord and placenta after the delivery of a newborn. Before the birth of the baby, stem cells and immune cells are transferred from the mother to the fetus in order to boost the immune systems of the mother and baby in preparation for labor. Thus, at the time of delivery, the blood in the umbilical cord is a rich source of stem cells and other cells of the immune system. [Read more…]
Cord Blood Registry (CBR®) by Generate Life Sciences Partners with NantKwest to Develop Covid-19 Treatment
CBR to Provide Umbilical Cord-Derived Cellular Material to NantKwest for additional COVID-19 Clinical Trials Utilizing MSC Therapy
Los Angeles, Calif., and El Segundo, Calif., August 10, 2020 – CBR® by Generate Life Sciences, the world’s largest private newborn stem cell bank, and NantKwest (Nasdaq: NK), a clinical-stage, natural killer cell-based immunotherapy company, announced a collaboration to develop a COVID-19 treatment leveraging newborn stem cells. CBR will provide research-donated umbilical cord tissue-derived mesenchymal stem cells (MSCs) to NantKwest for efficient and robust expansion utilizing their proprietary modular, closed bioreactor system from NantKwest affiliate ImmunityBio, Inc. [Read more…]
Cord Blood as a Therapeutic Strategy for Cerebral Palsy
Cerebral palsy is a neurological condition that affects thousands of babies born every year. Damage or malformation of the brain during development, most often in the womb, leads to motor and muscle symptoms. Children with cerebral palsy face a lifelong disability with consequences ranging from being wheelchair bound to painful, tight muscles and joints and even hearing loss, vision loss, cognitive deficits, and many more symptoms and complications that vary by individual. [Read more…]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 31
- Next Page »




